AnGes,Inc.

4563 TSE Pharmaceuticals Pharmaceutical
TSE Growth
¥36.00
-7.69%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Moderate debt: debt-to-equity of 0.76.
  • Return on equity is healthy at 174.7%.
  • Current assets comfortably cover current liabilities (current ratio 1.96).
  • Sales have compounded about 72% a year over five years.

!Watch-points

  • Return on capital employed is on the lower side at -162.7%.
  • The company reported a net loss in the latest period.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
-15.98

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
3 / 4

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 4 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥144億
Current Price¥ 36.00
High / Low¥ 93.00 / 36.00
Stock P/E-2.49
Book Value¥ 7.67
Dividend Yield0%
ROCE-162.70%
ROE174.66%
Debt to Equity0.76
Current Ratio1.96
P/B Ratio70.03891
EPS¥ -14.44
PAT Margin-1691.71%
Compounded Sales Growth
10 Years
5 Years 71.92%
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year 174.66%
Educational data only. Not a recommendation to buy, sell or hold any security.